Ladenburg Thalmann Financial Services’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $33K | Buy |
865
+365
| +73% | +$13.9K | ﹤0.01% | 3809 |
|
|
2019
Q3 | $12K | Sell |
500
-1,800
| -78% | -$43.2K | ﹤0.01% | 4291 |
|
|
2019
Q2 | $66K | Hold |
2,300
| – | – | ﹤0.01% | 3258 |
|
|
2019
Q1 | $65K | Hold |
2,300
| – | – | ﹤0.01% | 3215 |
|
|
2018
Q4 | $53K | Hold |
2,300
| – | – | ﹤0.01% | 3201 |
|
|
2018
Q3 | $79K | Sell |
2,300
-23,621
| -91% | -$811K | ﹤0.01% | 2987 |
|
|
2018
Q2 | $849K | Hold |
25,921
| – | – | 0.01% | 1161 |
|
|
2018
Q1 | $849K | Buy |
25,921
+21,421
| +476% | +$702K | 0.01% | 1161 |
|
|
2017
Q4 | $128K | Buy |
4,500
+1,500
| +50% | +$42.7K | ﹤0.01% | 2531 |
|
|
2017
Q3 | $87K | Hold |
3,000
| – | – | ﹤0.01% | 2692 |
|
|
2017
Q2 | $72K | Buy |
3,000
+100
| +3% | +$2.4K | ﹤0.01% | 2735 |
|
|
2017
Q1 | $67K | Sell |
2,900
-200
| -6% | -$4.62K | ﹤0.01% | 2676 |
|
|
2016
Q4 | $57K | Sell |
3,100
-550
| -15% | -$10.1K | ﹤0.01% | 2743 |
|
|
2016
Q3 | $83K | Sell |
3,650
-651
| -15% | -$14.8K | ﹤0.01% | 2389 |
|
|
2016
Q2 | $77K | Sell |
4,301
-200
| -4% | -$3.58K | ﹤0.01% | 2345 |
|
|
2016
Q1 | $86K | Hold |
4,501
| – | – | ﹤0.01% | 2167 |
|
|
2015
Q4 | $131K | Sell |
4,501
-499
| -10% | -$14.5K | ﹤0.01% | 1868 |
|
|
2015
Q3 | $132K | Buy |
5,000
+2,800
| +127% | +$73.9K | ﹤0.01% | 1789 |
|
|
2015
Q2 | $80K | Buy |
+2,200
| New | +$80K | ﹤0.01% | 2253 |
|